Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 9 studies | 21% ± 5% | |
| epithelial cell | 5 studies | 23% ± 5% | |
| glutamatergic neuron | 4 studies | 38% ± 16% | |
| astrocyte | 4 studies | 23% ± 4% | |
| macrophage | 4 studies | 22% ± 2% | |
| classical monocyte | 3 studies | 25% ± 6% | |
| GABAergic neuron | 3 studies | 35% ± 8% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 29% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 5304.08 | 1445 / 1445 | 100% | 12.68 | 183 / 183 |
| prostate | 100% | 7954.77 | 245 / 245 | 100% | 18.22 | 501 / 502 |
| skin | 100% | 4778.48 | 1808 / 1809 | 100% | 20.68 | 471 / 472 |
| intestine | 100% | 6290.98 | 966 / 966 | 99% | 14.58 | 522 / 527 |
| lung | 100% | 8036.76 | 578 / 578 | 99% | 15.49 | 1144 / 1155 |
| thymus | 100% | 10876.30 | 653 / 653 | 99% | 24.79 | 599 / 605 |
| stomach | 100% | 5109.26 | 359 / 359 | 99% | 12.56 | 283 / 286 |
| pancreas | 100% | 3818.85 | 328 / 328 | 99% | 18.83 | 176 / 178 |
| bladder | 100% | 6989.67 | 21 / 21 | 99% | 14.61 | 498 / 504 |
| kidney | 100% | 6159.93 | 89 / 89 | 99% | 20.09 | 890 / 901 |
| adrenal gland | 100% | 8538.37 | 258 / 258 | 99% | 20.59 | 227 / 230 |
| breast | 100% | 8077.30 | 459 / 459 | 99% | 12.32 | 1102 / 1118 |
| ovary | 100% | 9007.79 | 180 / 180 | 98% | 13.06 | 422 / 430 |
| uterus | 100% | 8761.34 | 170 / 170 | 97% | 13.99 | 446 / 459 |
| liver | 99% | 3366.13 | 224 / 226 | 95% | 13.22 | 386 / 406 |
| brain | 94% | 3605.13 | 2483 / 2642 | 100% | 24.30 | 704 / 705 |
| adipose | 100% | 7700.82 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 8170.25 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 6.60 | 1 / 1 |
| blood vessel | 100% | 6464.75 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 4532.56 | 801 / 803 | 0% | 0 | 0 / 0 |
| heart | 99% | 4637.41 | 855 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 20.99 | 79 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 10.38 | 44 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 93% | 12.25 | 27 / 29 |
| peripheral blood | 88% | 2921.02 | 814 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0009313 | Biological process | oligosaccharide catabolic process |
| GO_0006013 | Biological process | mannose metabolic process |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0004559 | Molecular function | alpha-mannosidase activity |
| GO_0030246 | Molecular function | carbohydrate binding |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | MAN2C1 |
| Protein name | Alpha-mannosidase 2C1 (EC 3.2.1.24) (Alpha mannosidase 6A8B) (Alpha-D-mannoside mannohydrolase) (Mannosidase alpha class 2C member 1) Mannosidase alpha class 2C member 1 (cDNA FLJ57925, highly similar to Alpha-mannosidase 2C1) alpha-mannosidase (EC 3.2.1.24) Mannosidase alpha class 2C member 1 |
| Synonyms | MANA hCG_1739384 MANA1 |
| Description | FUNCTION: Cleaves alpha 1,2-, alpha 1,3-, and alpha 1,6-linked mannose residues on cytoplasmatic free oligosaccharides generated by N-glycoprotein degradation pathways. . |
| Accessions | ENST00000569355.5 H3BQJ2 H3BRI3 ENST00000566634.5 ENST00000565683.5 [Q9NTJ4-4] ENST00000569482.5 [Q9NTJ4-2] ENST00000562071.5 ENST00000267978.10 [Q9NTJ4-1] H3BQH9 H3BMJ3 ENST00000565784.5 H3BSE5 H3BUW3 ENST00000561615.1 ENST00000570257.6 Q9NTJ4 ENST00000563622.5 [Q9NTJ4-3] ENST00000421803.6 ENST00000568374.5 B4DH23 H3BRV3 A0A140VJN9 ENST00000566256.5 |
